Clinical trial
Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment (Prednisone 5 Milligram Per Day) in Quiescent Systemic Lupus
NCT02558517 is registered in ClinicalTrials.gov with Groupe Hospitalier Pitie-Salpetriere as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment (Prednisone 5 Milligram Per Day) in Quiescent Systemic Lupus
- Lead sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- January 31, 2018
- Enrollment
- 136 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
systemic lupus erythematosus